Literature DB >> 34580752

Endoplasmic reticulum stress-related secretory proteins as biomarkers of early myocardial ischemia-induced sudden cardiac deaths.

Bokang Yu1, Chenchao Xu1, Xinru Tang1, Zheng Liu1, Xinyi Lin1, Hang Meng2, Cheng Shi3, Kaijun Ma2, Bi Xiao2, Liliang Li4.   

Abstract

Early myocardial ischemia-induced sudden cardiac deaths (EMI-SCD) remain a great diagnostic challenge for forensic pathologists due to no gross or non-specific histological pathology. The goal of this study was to assess whether three secretory proteins, related with cellular endoplasmic reticulum stress, can be applied in forensic diagnosis of EMI-SCD. These markers included LMAN2, CAPN-1, and VCP and were compared with two clinically used markers (CK-MB and cTnI). A total of 21 EMI-SCD cases with a mean age of 53.0 (± 10.5) years and a mean ischemia interval of < 2.77 (± 2.56) hours were collected. Another 23 cases (mean 44.6 ± 15.0 year old) that died from non-cardiac causes served as control. Enzyme-linked immunosorbent assay (ELISA) was performed to detect target proteins' serum concentrations in the EMI-SCD and control groups. We found that LMAN2, CAPN-1, and VCP were all significantly increased in the EMI-SCD group as compared with control serum, with the fold changes ranging from 1.48 (p = 0.0022, LMAN2), 1.33 (p = 0.041, CAPN-1), to 1.26 (p = 0.021, VCP), respectively. The concentrations of these proteins remained highly stable within 6 h and were not affected by death time, postmortem interval (< 4 h), age, and month at death. Receiver operating characteristic (ROC) curves showed that the areas under the curve (AUC) were 0.8178 (LMAN2), 0.6988 (CAPN-1), and 0.7267 (VCP), all of which were higher than CK-MB (AUC 0.5590) and cTn-I (AUC 0.5911). The diagnostic specificity (all above 60%) was obviously higher than CK-MB (43.48%) and cTnI (34.78%). In conclusion, LMAN-2, CAPN-1, and VCP could be stable serological biomarkers for diagnosis of EMI-SCD cases.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Early myocardial ischemia; Forensic diagnosis; Serum samples; Sudden cardiac death

Mesh:

Substances:

Year:  2021        PMID: 34580752     DOI: 10.1007/s00414-021-02702-z

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  45 in total

Review 1.  Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques.

Authors:  S O Vargas; B A Sampson; F J Schoen
Journal:  Mod Pathol       Date:  1999-06       Impact factor: 7.842

Review 2.  The spectrum of epidemiology underlying sudden cardiac death.

Authors:  Meiso Hayashi; Wataru Shimizu; Christine M Albert
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 3.  Modulation of the myocardial response to ischemia.

Authors:  L M Buja
Journal:  Lab Invest       Date:  1998-11       Impact factor: 5.662

Review 4.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

Review 5.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

6.  The histopathologic evolution of myocardial infarction.

Authors:  M C Fishbein; D Maclean; P R Maroko
Journal:  Chest       Date:  1978-06       Impact factor: 9.410

7.  Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death.

Authors:  Sara Sabatasso; Milena Moretti; Patrice Mangin; Tony Fracasso
Journal:  Int J Legal Med       Date:  2017-05-11       Impact factor: 2.686

Review 8.  Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives.

Authors:  Christopher X Wong; Alex Brown; Dennis H Lau; Sumeet S Chugh; Christine M Albert; Jonathan M Kalman; Prashanthan Sanders
Journal:  Heart Lung Circ       Date:  2018-09-24       Impact factor: 2.975

9.  Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers.

Authors:  Carlo P Campobasso; Alessandro S Dell'Erba; Annalisa Addante; Fiorenza Zotti; Andrea Marzullo; Massimo F Colonna
Journal:  Am J Forensic Med Pathol       Date:  2008-06       Impact factor: 0.921

10.  Diagnosis of sudden cardiac death due to early myocardial ischemia: An ultrastructural and immunohistochemical study.

Authors:  Silvia Damiana Visonà; Donatella Benati; Maria Cristina Monti; Mirco Galiè; Luisa Andrello; Andrea Frontini; Antonio Osculati
Journal:  Eur J Histochem       Date:  2018-04-03       Impact factor: 3.188

View more
  4 in total

1.  Serum TP53 Protein Level as a Sensitive Biomarker for the Diagnosis of Myocardial Damage in Children.

Authors:  Xianglin Zeng; Chunwang Lin; Yanna Sun; Jianping Zhang
Journal:  Med Sci Monit       Date:  2022-06-25

2.  Valosin Containing Protein as a Specific Biomarker for Predicting the Development of Acute Coronary Syndrome and Its Complication.

Authors:  Chenchao Xu; Bokang Yu; Xin Zhao; Xinyi Lin; Xinru Tang; Zheng Liu; Pan Gao; Junbo Ge; Shouyu Wang; Liliang Li
Journal:  Front Cardiovasc Med       Date:  2022-03-18

3.  Correlation between Carbonic Anhydrase Isozymes and the Evolution of Myocardial Infarction in Diabetic Patients.

Authors:  Sorina Magheru; Calin Magheru; Florin Maghiar; Liliana Sachelarie; Felicia Marc; Corina Maria Moldovan; Laura Romila; Anica Hoza; Dorina Maria Farcas; Irina Gradinaru; Loredana Liliana Hurjui
Journal:  Biology (Basel)       Date:  2022-08-08

4.  Quantitative Proteomics of Medium-Sized Extracellular Vesicle-Enriched Plasma of Lacunar Infarction for the Discovery of Prognostic Biomarkers.

Authors:  Arnab Datta; Christopher Chen; Yong-Gui Gao; Siu Kwan Sze
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.